Join Abbott at ECCMID 2019
See how we are transforming healthcare at the point of care.
The rapid advances in infectious disease detection, infection control, treatment and monitoring are discussed by the world’s experts during this congress. Abbott is honored to be there among them for the 29th European Congress of Clinical Microbiology and Infectious Diseases.
Laboratory and clinical experts constantly look for new approaches to diagnose earlier in the patient care pathway; improving process efficiencies, costs and patient outcomes. The strategic use of POC testing, both as an adjunct and as an alternative to conventional laboratory testing, enable faster results and better decisions to allow patients to live their life to the fullest.
Delivering POCT when time is critical
We deliver annually over 1 billion tests covering 100 disease states in more than 100 countries. Our rapid diagnostic tests are designed to help doctors, clinicians and caregivers in every care setting find answers more quickly when health outcomes are at stake. Find out more about the products below and at our booth #1.56.
Get the complete diagnostic picture with just one test.
The C. DIFF QUIK CHEK COMPLETE test provides a comprehensive diagnostic picture unlike any other standalone test. Incoming samples are simultaneously tested for GDH and Toxins A & B as recommended by the updated IDSA/SHEA Guidelines* and ESCMID Guidelines**, providing actionable C. difficile results in less than 30 minutes.
New - Come to our booth to learn more about it.
Rapid and Accurate Detection of More Acute HIV Infections.
The 4th generation Alere HIV Combo test helps close the window period and enables increased case finding at a time when individuals are highly infectious. Identifying HIV-positive patients now not only facilitates fast and appropriate linkage to care - it helps to prevent further transmission of the disease.
The world's most sensitive rapid diagnostic test for detection of hepatitis B surface antigen.6,7,8
Determine HBsAg 2, with an analytical sensitivity of just 0.1 IU/mL, is a highly sensitive, easy to use rapid lateral flow test that enables quick, accurate identification of HBsAg positive patients earlier. Increase HBV case finding and facilitate fast and appropriate linkage to care in any healthcare setting.